After finishing at $26.58 in the prior trading day, Protagonist Therapeutics Inc (NASDAQ: PTGX) closed at $26.11, down -1.77%. On the day, 524120 shares were traded.
Ratios:
Our goal is to gain a better understanding of PTGX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.71 and its Current Ratio is at 16.71. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, CapitalOne on October 30, 2023, initiated with a Overweight rating and assigned the stock a target price of $32.
On August 25, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $21.JMP Securities initiated its Mkt Outperform rating on August 25, 2022, with a $21 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 01 ’24 when PATEL DINESH V PH D sold 25,000 shares for $28.31 per share. The transaction valued at 707,750 led to the insider holds 549,590 shares of the business.
PATEL DINESH V PH D sold 30,000 shares of PTGX for $948,600 on Mar 01 ’24. The President and CEO now owns 574,590 shares after completing the transaction at $31.62 per share. On Mar 01 ’24, another insider, Ali Asif, who serves as the Chief Financial Officer of the company, sold 14,248 shares for $32.24 each. As a result, the insider received 459,318 and left with 38,397 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 25.36 while its Price-to-Book (P/B) ratio in mrq is 4.48.
Stock Price History:
Over the past 52 weeks, PTGX has reached a high of $33.34, while it has fallen to a 52-week low of $13.72.
Shares Statistics:
A total of 57.71M shares are outstanding, with a floating share count of 54.80M. Insiders hold about 5.96% of the company’s shares, while institutions hold 95.66% stake in the company.
